The Development of ATM Inhibitors in Cancer Therapy
Recent Publications (click on image to view)
2024
Nature Communications
Dormant origin firing promotes head-on transcription-replication conflicts at transcription termination sites in response to BRCA2 deficiency.
2021
Genes
Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
2022
Cancer Biology
BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair
2016
Nucleic Acids Research
Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity
2022
Frontiers in Genetics
The Pathogenic R3052W BRCA2 Variant Disrupts Homology-Directed Repair by Failing to Localize to the Nucleus
See Full Publication List or Google Scholar for Complete Publication Listing